Group One Trading’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,600
| Closed | -$511K | – | 7363 |
|
|
2020
Q3 | $511K | Buy |
4,600
+4,500
| +4,500% | +$483K | ﹤0.01% | 2826 |
|
|
2020
Q2 | $10K | Sell |
100
-1,900
| -95% | -$203K | ﹤0.01% | 5144 |
|
|
2020
Q1 | $216K | Sell |
2,000
-31,200
| -94% | -$3.58M | ﹤0.01% | 2689 |
|
|
2019
Q4 | $3.86M | Sell |
33,200
-67,400
| -67% | -$7.81M | 0.03% | 844 |
|
|
2019
Q3 | $11.5M | Buy |
100,600
+53,300
| +113% | +$5.3M | 0.09% | 232 |
|
|
2019
Q2 | $4.51M | Buy |
47,300
+24,300
| +106% | +$2.29M | 0.04% | 582 |
|
|
2019
Q1 | $2.1M | Buy |
23,000
+15,600
| +211% | +$1.28M | 0.02% | 903 |
|
|
2018
Q4 | $562K | Sell |
7,400
-12,300
| -62% | -$905K | ﹤0.01% | 1916 |
|
|
2018
Q3 | $1.58M | Buy |
19,700
+13,700
| +228% | +$1.28M | 0.01% | 1331 |
|
|
2018
Q2 | $596K | Buy |
+6,000
| New | +$518K | 0.01% | 2157 |
|
|
2017
Q2 | – | Sell |
-500
| Closed | -$50K | – | 5416 |
|
|
2017
Q1 | $50K | Buy |
+500
| New | +$53.4K | ﹤0.01% | 3410 |
|
|
2016
Q4 | – | Sell |
-20,600
| Closed | -$2.56M | – | 5146 |
|
|
2016
Q3 | $2.56M | Sell |
20,600
-3,500
| -15% | -$413K | 0.03% | 715 |
|
|
2016
Q2 | $2.56M | Buy |
24,100
+19,300
| +402% | +$2.24M | 0.03% | 678 |
|
|
2016
Q1 | $550K | Buy |
4,800
+3,100
| +182% | +$364K | 0.01% | 1615 |
|
|
2015
Q4 | $242K | Sell |
1,700
-3,600
| -68% | -$416K | ﹤0.01% | 2359 |
|
|
2015
Q3 | $476K | Buy |
5,300
+5,200
| +5,200% | +$549K | 0.01% | 1823 |
|
|
2015
Q2 | $12K | Sell |
100
-900
| -90% | -$94.6K | ﹤0.01% | 4248 |
|
|
2015
Q1 | $96K | Buy |
+1,000
| New | +$74.8K | ﹤0.01% | 2932 |
|
Group One Trading's CBPO Position: Q2 2021 in Review
Group One Trading sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 285 shares — an estimated $34K sold.
Group One Trading first reported a position in CBPO in Q3 2015 and held it in 13 quarters. The position peaked at $8.01M in Q3 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Group One Trading reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Group One Trading sold 285 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $34K.
- Group One Trading first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 13 quarters.
- Group One Trading's China Biologic Products Holdings, Inc. position peaked at $8.01M in Q3 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.